Bacterial Vaginosis Drug Market Scope And Analysis

  • Report Code : TIPRE00018820
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 184
Buy Now

Bacterial Vaginosis Drug Market Trends and Scope by 2031

Buy Now

Bacterial Vaginosis Drug Market Report Bacterial Vaginosis Drug Market Size and Share Bacterial Vaginosis Drug Market Scope and Analysis

Bacterial Vaginosis Drug Market Report Scope

Report Attribute Details
Market size in 2024 US$ 2.15 Billion
Market Size by 2031 US$ 3.82 Billion
Global CAGR (2024 - 2031) 8.3%
Historical Data 2021-2023
Forecast period 2024-2031
Segments Covered By Type
  • Prescription Drugs
  • Over-the-counter Drugs
By Route Of Administration
  • Oral
  • Vaginal
  • Topical
By Dosage Form
  • Pills
  • Creams
  • Gel
  • Solution or Washes
By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bayer AG
  • Pfizer Inc
  • Sanofi SA
  • Starpharma Holdings Limited
  • Viatris Inc
  • Glenmark Pharmaceuticals Ltd
  • Lupin Ltd
  • Sun Pharmaceutical Industries Ltd
  • Organon Co
  • Duchesnay Inc Canada
    		•